Patterns of Treatment and Real‐World Outcomes of Patients With Non‐small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study

ABSTRACT Background Real‐world data regarding patients with non‐small cell lung cancer (NSCLC) with EGFR exon 20 insertion (ex20ins) mutations receiving mobocertinib are limited. This study describes these patients' characteristics and outcomes. Methods A chart review was conducted across three...

Full description

Saved in:
Bibliographic Details
Main Authors: Geoffrey Liu, Shi Feng Nyaw, Tony S. K. Mok, Hubert Curcio, Alexis B. Cortot, Tsz Yeung Kam, Renaud Descourt, Yin Kwan Chik, Parneet Cheema, James M. Gwinnutt, Eric N. Churchill, Justin Nyborn, Eileen Curran, Alexandra Savell, Yu Yin, Katie Chong, Yuka Tanaka‐Chambers, Julian Kretz, Jacques Cadranel
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.70369
Tags: Add Tag
No Tags, Be the first to tag this record!